EP1948217
USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.8.2006:
4.1.2012:
06780613.3
:
USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE
11.8.2006
4.1.2012
:
Anabasis s.r.l.:
San Martino 12, 20122, Milano, IT
:
LAMBIASE, Alessandro:
Roma, IT
:
BONINI, Stefano:
Roma, IT
:
RM20050447:
19.8.2005:
IT
:
WO2007020672:
11.8.2006
:
A61K 38/18, A61P 25/00